Abcellera twitter sentiment
Twitter users highlight Veozah (Fezolinetant) 3--phase data showing CNS safety similar to placebo, validating NK3R market for hot flashes but with liver monitoring burden; this indirectly positive for $ABCL's ABCL635 (same target, antibody with no liver tox in Ph1, potential monthly dosing) as differentiation if efficacy matches in Q3 2026 Ph2.
Sources
- https://x.com/i/status/2066648570883661931
- https://x.com/i/status/2066668969596264495
- https://x.com/i/status/2066663671086952783
- https://x.com/i/status/2065766002478944404
- https://x.com/i/status/2066655015192670426
- https://x.com/i/status/2065980697131565296
- https://x.com/i/status/2066102251781792133
- https://x.com/i/status/2066643178141180008
- https://x.com/i/status/2066164174938357836
- https://x.com/i/status/2065785772641341929
- https://x.com/i/status/
- https://x.com/i/status/2065781457017041239
- https://x.com/i/status/2066671297900552419
- https://x.com/i/status/2066181373723894019